Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

The BiaB advantages over traditional methods of RNA manufacturing, include high throughput of high-quality pharmaceutical ...

GMP compliant manufacturing of Gemini is a pivotal requirement for an Investigational New Drug (IND) application with FDA. The Company intends to utilize the current supply of Gemini for the ...

The Cebu Provincial Government has signed a memorandum of agreement with the Department of Science and Technology and the Food and Drugs Administration to improve the quality of products produced by ...

Quotient Sciences, a leading global drug development and manufacturing accelerator, today announced the installation of Centillion’s™ proprietary Biofoundry-in-a-Box (BiaB™), the first multi-product ...

The GMP inspection, conducted by EMA representatives from April 8-12, 2024, assessed mammalian and microbial drug substance ...

Venus Remedies’ Baddi robotic pre-filled syringe facility receives Malaysian PIC/S GMP approval: Our Bureau, Mumbai Tuesday, November 5, 2024, 12:15 Hrs [IST] Venus Remedies Lim ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and ...